Kara, I. O. Et Al. 2006. Clinical significance of hepatocyte growth factor, platelet-derived growth factor-AB, and transforming growth factor-alpha in bone marrow and peripheral blood of patients with multiple myeloma. ADVANCES IN THERAPY , vol.23, no.4 , 635-645.

Kara, I. O., Sahin, B., Gunesacar, R., & Unsal, C., (2006). Clinical significance of hepatocyte growth factor, platelet-derived growth factor-AB, and transforming growth factor-alpha in bone marrow and peripheral blood of patients with multiple myeloma. ADVANCES IN THERAPY , vol.23, no.4, 635-645.

Kara, İSMAİL Et Al. "Clinical significance of hepatocyte growth factor, platelet-derived growth factor-AB, and transforming growth factor-alpha in bone marrow and peripheral blood of patients with multiple myeloma," ADVANCES IN THERAPY , vol.23, no.4, 635-645, 2006

Kara, İSMAİL O. Et Al. "Clinical significance of hepatocyte growth factor, platelet-derived growth factor-AB, and transforming growth factor-alpha in bone marrow and peripheral blood of patients with multiple myeloma." ADVANCES IN THERAPY , vol.23, no.4, pp.635-645, 2006

Kara, I. O. Et Al. (2006) . "Clinical significance of hepatocyte growth factor, platelet-derived growth factor-AB, and transforming growth factor-alpha in bone marrow and peripheral blood of patients with multiple myeloma." ADVANCES IN THERAPY , vol.23, no.4, pp.635-645.

@article{article, author={İSMAİL OĞUZ KARA Et Al. }, title={Clinical significance of hepatocyte growth factor, platelet-derived growth factor-AB, and transforming growth factor-alpha in bone marrow and peripheral blood of patients with multiple myeloma}, journal={ADVANCES IN THERAPY}, year=2006, pages={635-645} }